This study was conducted to evaluate the expression patterns and clinical significance of octamer-binding transcription factor 4 (OCT4) and NANOG as the key stem cell factors in renal cell carcinoma (RCC). This evidence concerns the gene NANOG and hereditary clear cell renal cell carcinoma.